Insider Trading activities of Quest Diagnostics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quest Diagnostics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Quest Diagnostics Inc since year 2005. Table 2 shows the detailed insider transactions of Quest Diagnostics Inc since 2005. The reporting company's ticker symbol is DGX. The reporting company's CIK number is 1022079.
The total value of stock buying since 2005 is $1,959,690.
The total value of stock sales since 2005 is $2,281,950,516.
The total value of stock option exercises since 2005 is $205,391,210.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Quest Diagnostics Inc (DGX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 106,463 $11,510,315 106,463 $6,160,798
2017-08 0 $0 296 $31,571 0 $0
2017-07 0 $0 1,304 $141,782 0 $0
2017-06 0 $0 166,662 $17,972,200 166,662 $9,319,177
2017-04 0 $0 35,624 $3,587,027 35,624 $2,012,084
2017-03 0 $0 26,097 $2,588,700 13,987 $778,376
2017-02 0 $0 50,255 $4,656,742 45,000 $2,404,125
2017-01 0 $0 80,000 $7,264,720 80,000 $4,331,440
2016-11 0 $0 42,643 $3,628,492 34,333 $1,948,500
2016-08 0 $0 14,345 $1,223,156 14,641 $910,159
2016-07 0 $0 1,000 $84,359 0 $0
2016-05 0 $0 154,093 $11,784,675 154,093 $9,263,442
2016-04 0 $0 29,550 $2,199,406 23,667 $1,211,750
2016-03 0 $0 3,815 $260,965 0 $0
2015-08 0 $0 4,466 $326,722 0 $0
2015-03 0 $0 3,261 $232,042 0 $0
2015-02 0 $0 35,768 $2,570,378 32,000 $1,610,960
2014-11 0 $0 203,696 $12,831,686 203,696 $10,988,013
2014-08 0 $0 39,377 $2,380,083 39,377 $2,012,513
2014-07 0 $0 44,384 $2,763,605 44,384 $2,235,955
2014-05 4,000 $222,024 12,973 $730,918 10,998 $538,242
2014-04 0 $0 30,000 $1,672,380 30,000 $1,374,960
2014-03 0 $0 778 $41,233 0 $0
2014-02 5,000 $253,525 73,687 $3,873,238 70,000 $3,240,320
2013-11 0 $0 41,564 $2,634,647 40,906 $2,021,877
2013-10 0 $0 16,000 $947,800 14,000 $654,967
2013-09 0 $0 43,334 $2,686,708 43,334 $2,263,984
2013-08 0 $0 45,817 $2,735,807 45,000 $1,819,259
2013-07 0 $0 4,200 $247,766 0 $0
2013-06 0 $0 126,667 $7,934,172 126,667 $5,810,628
2013-05 0 $0 42,576 $2,588,576 41,362 $1,951,678
2013-04 0 $0 1,470 $85,774 1,470 $57,268
2013-03 0 $0 4,762 $269,722 0 $0
2013-02 0 $0 16,923 $970,834 10,000 $554,000
2013-01 0 $0 10,000 $600,000 10,000 $554,000
2012-10 0 $0 46,667 $2,986,688 46,667 $1,886,653
2012-09 0 $0 10,000 $623,190 10,000 $554,000
2012-08 5,000 $296,675 191,015 $11,312,011 186,445 $7,868,299
2012-07 0 $0 58,814 $3,548,269 70,222 $2,283,736
2012-06 0 $0 36,460 $2,160,700 36,460 $1,438,061
2012-05 20,000 $1,137,740 23,504 $1,362,210 18,864 $957,548
2012-04 0 $0 46,666 $2,893,292 46,666 $1,886,613
2012-03 0 $0 7,207 $413,652 0 $0
2012-02 0 $0 62,534 $3,625,634 56,528 $3,021,506
2012-01 0 $0 663,890 $39,154,686 573,890 $25,733,029
2011-12 0 $0 28,856 $1,672,205 28,856 $1,351,627
2011-11 0 $0 49,690 $2,761,817 49,690 $2,357,401
2011-10 0 $0 254,603 $14,420,294 254,603 $10,504,102
2011-09 0 $0 8,300 $412,861 8,300 $349,728
2011-08 0 $0 5,650 $277,288 4,150 $174,864
2011-07 0 $0 28,855 $1,694,117 28,855 $1,351,578
2011-06 0 $0 63,953 $3,783,166 44,855 $2,131,418
2011-05 0 $0 104,141 $5,976,273 90,522 $4,280,142
2011-04 0 $0 28,855 $1,667,647 28,855 $1,351,578
2011-03 0 $0 31,451 $1,776,299 28,855 $1,351,578
2011-02 0 $0 428,047 $24,860,228 392,827 $14,695,123
2011-01 0 $0 30,755,151 $1,690,241,588 0 $0
2010-05 0 $0 3,571 $203,732 3,571 $88,417
2010-04 0 $0 3,571 $209,464 3,571 $88,417
2010-03 0 $0 3,571 $204,164 3,571 $88,417
2010-02 0 $0 230,197 $13,130,099 234,552 $6,012,674
2009-11 0 $0 61,567 $3,521,839 65,800 $2,550,224
2009-10 0 $0 4,330 $246,227 11,449 $407,404
2009-08 0 $0 71,967 $3,909,221 53,736 $1,872,732
2009-07 0 $0 362,992 $20,179,635 327,718 $9,386,308
2009-03 0 $0 5,749,157 $257,784,615 0 $0
2009-02 0 $0 90,883 $4,646,125 81,180 $2,486,255
2008-11 0 $0 134,500 $6,329,745 133,832 $6,299,051
2007-07 0 $0 12,502 $693,948 12,502 $510,644
2007-05 0 $0 0 $0 2,092 $41,578
2007-02 0 $0 168,437 $8,787,971 170,135 $4,441,916
2006-10 1,000 $49,726 102,000 $5,058,384 102,000 $2,592,534
2006-05 0 $0 342,559 $19,767,924 326,722 $4,849,036
2006-02 0 $0 57,647 $3,063,822 69,767 $2,118,544
2005-05 0 $0 5,000 $531,285 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Quest Diagnostics Inc insiders (DGX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-12 Rusckowski Stephen H (Chairman, President and CEO) Sale 5,302 108.12 573,236
2017-09-12 Rusckowski Stephen H (Chairman, President and CEO) Option Ex 5,302 58.17 308,443
2017-09-11 Stanzione Daniel Sale 40,900 108.07 4,419,940
2017-09-11 Stanzione Daniel Option Ex 40,900 57.51 2,352,077
2017-09-11 Rusckowski Stephen H (Chairman, President and CEO) Sale 53,933 108.16 5,833,609
2017-09-11 Rusckowski Stephen H (Chairman, President and CEO) Option Ex 53,933 58.17 3,137,552
2017-09-05 Stanzione Daniel Sale 3,803 108.01 410,762
2017-09-05 Stanzione Daniel Option Ex 3,803 56.75 215,835
2017-09-05 Rusckowski Stephen H (Chairman, President and CEO) Sale 2,525 108.03 272,768
2017-09-05 Rusckowski Stephen H (Chairman, President and CEO) Option Ex 2,525 58.17 146,891
2017-08-04 Leiden Jeffrey M Sale 296 106.66 31,571
2017-07-27 Leiden Jeffrey M Sale 1,304 108.73 141,782
2017-06-19 Doherty Catherine T. (SVP, Group Exec. Clin. Fran.) Sale 59,762 107.84 6,444,853
2017-06-19 Doherty Catherine T. (SVP, Group Exec. Clin. Fran.) Option Ex 59,762 57.02 3,407,928
2017-06-19 Cohen Jon R (SVP & Group Exec. Diag. Sol.) Sale 106,900 107.83 11,527,347
2017-06-19 Cohen Jon R (SVP & Group Exec. Diag. Sol.) Option Ex 106,900 55.30 5,911,249
2017-04-24 Britell Jenne K Sale 6,111 104.03 635,727
2017-04-24 Britell Jenne K Option Ex 6,111 57.67 352,421
2017-04-20 Prevoznik Michael E (SVP & General Counsel) Sale 29,513 100.00 2,951,300
2017-04-20 Prevoznik Michael E (SVP & General Counsel) Option Ex 29,513 56.23 1,659,663
2017-03-16 Prevoznik Michael E (SVP & General Counsel) Sale 13,987 100.00 1,398,700
2017-03-16 Prevoznik Michael E (SVP & General Counsel) Option Ex 13,987 55.65 778,376
2017-03-03 Doherty Catherine T. (SVP, Group Exec. Clin. Fran.) Sale 6,028 98.29 592,492
2017-03-03 Prevoznik Michael E (SVP & General Counsel) Sale 4,478 98.29 440,142
2017-03-02 Doherty Catherine T. (SVP, Group Exec. Clin. Fran.) Sale 1,134 98.25 111,415
2017-03-01 Prevoznik Michael E (SVP & General Counsel) Sale 470 97.77 45,951
2017-02-27 Prevoznik Michael E (SVP & General Counsel) Sale 440 97.39 42,851
2017-02-22 Ziegler John B Sale 2,000 95.51 191,016
2017-02-15 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Sale 1,615 94.65 152,858
2017-02-13 Prevoznik Michael E (SVP & General Counsel) Sale 1,200 93.76 112,512
2017-02-02 Prevoznik Michael E (SVP & General Counsel) Sale 45,000 92.39 4,157,505
2017-02-02 Prevoznik Michael E (SVP & General Counsel) Option Ex 45,000 53.42 2,404,125
2017-01-30 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Sale 80,000 90.81 7,264,720
2017-01-30 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Option Ex 80,000 54.14 4,331,440
2016-11-15 Pfeiffer Gary M Sale 42,643 85.09 3,628,492
2016-11-15 Pfeiffer Gary M Option Ex 34,333 56.75 1,948,500
2016-08-19 Britell Jenne K Sale 4,000 84.76 339,052
2016-08-19 Britell Jenne K Option Ex 4,000 55.76 223,040
2016-08-10 Britell Jenne K Sale 4,000 85.20 340,808
2016-08-10 Britell Jenne K Option Ex 4,000 55.76 223,040
2016-08-03 Leiden Jeffrey M Sale 6,345 85.63 543,296
2016-08-03 Leiden Jeffrey M Option Ex 6,641 69.88 464,079
2016-07-25 Ziegler John B Sale 1,000 84.36 84,359
2016-05-27 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Sale 47,334 77.27 3,657,308
2016-05-27 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Option Ex 47,334 56.23 2,661,827
2016-05-09 Cunningham Everett (SVP, Commercial) Sale 56,312 76.24 4,293,395
2016-05-09 Cunningham Everett (SVP, Commercial) Option Ex 56,312 63.65 3,583,977
2016-05-06 Cunningham Everett (SVP, Commercial) Sale 50,447 76.00 3,833,972
2016-05-06 Cunningham Everett (SVP, Commercial) Option Ex 50,447 59.82 3,017,638
2016-04-25 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Sale 29,550 74.43 2,199,406
2016-04-25 Doherty Catherine T. (SVP, Clin. Franchise Solutions) Option Ex 23,667 51.20 1,211,750
2016-03-01 Prevoznik Michael E (SVP & General Counsel) Sale 3,815 68.41 260,965
2015-08-12 Baldwin John C Md Sale 2,266 72.00 163,152
2015-08-06 Ziegler John B Sale 2,200 74.35 163,570
2015-03-03 Prevoznik Michael E (SVP & General Counsel) Sale 3,261 71.16 232,042
2015-02-17 Guinan Mark (Senior Vice President & CFO) Sale 280 71.74 20,086
2015-02-17 Prevoznik Michael E (SVP & General Counsel) Sale 488 71.41 34,848
2015-02-11 Stanzione Daniel Sale 8,000 70.97 567,752
2015-02-11 Stanzione Daniel Option Ex 8,000 49.94 399,520
2015-02-04 Pfeiffer Gary M Sale 8,000 72.43 579,464
2015-02-04 Pfeiffer Gary M Option Ex 8,000 49.94 399,520
2015-02-04 Wilensky Gail R Sale 8,000 72.34 578,688
2015-02-04 Wilensky Gail R Option Ex 8,000 49.94 399,520
2015-02-03 Ziegler John B Sale 8,000 71.88 575,040
2015-02-03 Ziegler John B Option Ex 8,000 51.55 412,400
2015-02-02 Bongiorno Thomas F (VP and Corporate Controller) Sale 3,000 71.50 214,500
2014-11-18 Bongiorno Thomas F (VP and Corporate Controller) Sale 10,000 64.00 640,000
2014-11-18 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 10,000 47.49 474,900
2014-11-17 Cohen Jon R (SVP and Chief Medical Officer) Sale 98,152 63.00 6,183,576
2014-11-17 Cohen Jon R (SVP and Chief Medical Officer) Option Ex 83,483 56.69 4,732,818
2014-11-14 Cohen Jon R (SVP and Chief Medical Officer) Sale 61,877 63.34 3,919,289
2014-11-14 Cohen Jon R (SVP and Chief Medical Officer) Option Ex 76,546 54.56 4,176,120
2014-11-10 Pfeiffer Gary M Sale 10,000 61.69 616,900
2014-11-10 Pfeiffer Gary M Option Ex 10,000 48.02 480,230
2014-11-03 Doherty Catherine T. (SVP, Physician Services Bus.) Sale 23,667 62.19 1,471,921
2014-11-03 Doherty Catherine T. (SVP, Physician Services Bus.) Option Ex 23,667 47.49 1,123,945
2014-08-08 Doherty Catherine T. (SVP, Clinical Franchises) Sale 25,000 60.12 1,502,900
2014-08-08 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 25,000 53.19 1,329,750
2014-08-04 Prevoznik Michael E (SVP & General Counsel) Sale 14,377 61.01 877,183
2014-08-04 Prevoznik Michael E (SVP & General Counsel) Option Ex 14,377 47.49 682,763
2014-07-30 Prevoznik Michael E (SVP & General Counsel) Sale 16,384 62.51 1,024,098
2014-07-30 Prevoznik Michael E (SVP & General Counsel) Option Ex 16,384 47.49 778,076
2014-07-30 Britell Jenne K (Director) Sale 8,000 62.37 498,960
2014-07-30 Britell Jenne K (Director) Option Ex 8,000 49.94 399,520
2014-07-29 Baldwin John C Md (Director) Sale 8,000 62.31 498,480
2014-07-29 Baldwin John C Md (Director) Option Ex 8,000 55.76 446,080
2014-07-28 Bongiorno Thomas F (VP and Corporate Controller) Sale 4,000 61.72 246,868
2014-07-28 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 4,000 53.19 212,760
2014-07-25 Ziegler John B (Director) Sale 1,865 61.90 115,443
2014-07-25 Ziegler John B (Director) Option Ex 1,865 49.94 93,138
2014-07-24 Ziegler John B (Director) Sale 6,135 61.90 379,756
2014-07-24 Ziegler John B (Director) Option Ex 6,135 49.94 306,381
2014-05-22 Ziegler John B (Director) Sale 2,973 57.66 171,408
2014-05-22 Ziegler John B (Director) Option Ex 998 47.94 47,842
2014-05-07 Pfeiffer Gary M (Director) Sale 10,000 55.95 559,510
2014-05-07 Pfeiffer Gary M (Director) Option Ex 10,000 49.04 490,400
2014-05-05 Guinan Mark (Senior Vice President & CFO) Buy 4,000 55.51 222,024
2014-04-30 Stanzione Daniel (Director) Sale 30,000 55.75 1,672,380
2014-04-30 Stanzione Daniel (Director) Option Ex 30,000 45.83 1,374,960
2014-03-04 Prevoznik Michael E (SVP & General Counsel) Sale 778 53.00 41,233
2014-02-27 Prevoznik Michael E (SVP & General Counsel) Sale 827 52.99 43,826
2014-02-27 Britell Jenne K (Director) Sale 10,000 52.74 527,390
2014-02-27 Britell Jenne K (Director) Option Ex 10,000 49.04 490,400
2014-02-19 Prevoznik Michael E (SVP & General Counsel) Sale 2,860 52.26 149,472
2014-02-18 Wilensky Gail R (Director) Sale 30,000 52.94 1,588,110
2014-02-18 Wilensky Gail R (Director) Option Ex 30,000 45.83 1,374,960
2014-02-12 Buehler William F (Director) Sale 30,000 52.15 1,564,440
2014-02-12 Buehler William F (Director) Option Ex 30,000 45.83 1,374,960
2014-02-06 Main Timothy L (Director) Buy 5,000 50.70 253,525
2013-11-11 Prevoznik Michael E (SVP & General Counsel) Sale 24,239 64.02 1,551,683
2013-11-11 Prevoznik Michael E (SVP & General Counsel) Option Ex 24,239 47.49 1,151,110
2013-11-05 Baldwin John C Md (Director) Sale 658 63.00 41,454
2013-11-05 Bongiorno Thomas F (VP and Corporate Controller) Sale 8,000 63.00 504,000
2013-11-05 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 8,000 52.24 417,960
2013-11-04 Bongiorno Thomas F (VP and Corporate Controller) Sale 8,667 62.02 537,510
2013-11-04 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 8,667 52.24 452,807
2013-10-31 Baldwin John C Md (Director) Sale 8,000 59.70 477,600
2013-10-31 Baldwin John C Md (Director) Option Ex 8,000 51.55 412,400
2013-10-29 Bongiorno Thomas F (VP and Corporate Controller) Sale 6,000 59.00 354,000
2013-10-29 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 6,000 40.43 242,567
2013-10-25 Pfeiffer Gary M (Director) Sale 2,000 58.10 116,200
2013-09-17 Doherty Catherine T. (SVP, Clinical Franchises) Sale 27,621 62.00 1,712,502
2013-09-17 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 27,621 52.24 1,443,059
2013-09-16 Doherty Catherine T. (SVP, Clinical Franchises) Sale 15,713 62.00 974,206
2013-09-16 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 15,713 52.24 820,925
2013-08-14 Doherty Catherine T. (SVP, Clinical Franchises) Sale 33,000 59.85 1,975,116
2013-08-14 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 33,000 40.43 1,334,124
2013-08-12 Ziegler John B (Director) Sale 1,953 59.45 116,109
2013-08-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 10,864 59.33 644,582
2013-08-08 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 12,000 40.43 485,135
2013-07-23 Britell Jenne K (Director) Sale 4,200 58.99 247,766
2013-06-18 Prevoznik Michael E (SVP & General Counsel) Sale 9,921 62.46 619,685
2013-06-18 Prevoznik Michael E (SVP & General Counsel) Option Ex 9,921 40.43 401,086
2013-06-17 Prevoznik Michael E (SVP & General Counsel) Sale 116,746 62.65 7,314,487
2013-06-17 Prevoznik Michael E (SVP & General Counsel) Option Ex 116,746 46.34 5,409,542
2013-05-22 Ziegler John B (Director) Sale 31,362 62.00 1,944,444
2013-05-22 Ziegler John B (Director) Option Ex 31,362 44.57 1,397,678
2013-05-14 Baldwin John C Md (Director) Sale 1,214 59.41 72,122
2013-05-02 Wilensky Gail R (Director) Sale 10,000 57.20 572,010
2013-05-02 Wilensky Gail R (Director) Option Ex 10,000 55.40 554,000
2013-04-11 Ziegler John B (Director) Sale 1,470 58.35 85,774
2013-04-11 Ziegler John B (Director) Option Ex 1,470 38.96 57,268
2013-03-06 Prevoznik Michael E (SVP & General Counsel) Sale 2,770 56.64 156,892
2013-02-20 Ziegler John B (Director) Sale 2,000 57.42 114,840
2013-02-20 Britell Jenne K (Director) Sale 10,000 57.30 572,960
2013-02-20 Britell Jenne K (Director) Option Ex 10,000 55.40 554,000
2013-02-19 Prevoznik Michael E (SVP & General Counsel) Sale 1,442 57.53 82,961
2013-02-12 Prevoznik Michael E (SVP & General Counsel) Sale 3,481 57.48 200,073
2013-01-17 Pfeiffer Gary M (Director) Sale 10,000 60.00 600,000
2013-01-17 Pfeiffer Gary M (Director) Option Ex 10,000 55.40 554,000
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of DGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quest Diagnostics Inc (symbol DGX, CIK number 1022079) see the Securities and Exchange Commission (SEC) website.